Castle Biosciences, Inc. is a molecular diagnostics company, which offers innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
883
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Castle Biosciences Inc market cap is $1.02B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Castle Biosciences Inc 52 week high is $44.28 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Castle Biosciences Inc 52 week low is $17.72 as of November 18, 2026.
Castle Biosciences Inc stock price today is $33.38.
Castle Biosciences Inc stock price yesterday was $32.98.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Castle Biosciences Inc's P/E ratio is -43.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Castle Biosciences Inc P/B ratio is 2.1211.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Castle Biosciences Inc 50-day moving average is $34.35.